http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016072650-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ceacc0d4ea78a0c031481ea91ead628 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2d4e08365f471384fb441e644c8a7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ca40fca370633cbcf4fbde17e47817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b22d1039ccfec26d7e9b85bbf2b3c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde03e8fd9809a7000cf0cf70857964b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8d88410d206f4e5830067b8f1cfc90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35fbb65fbc7c35bc56dccafc741ea5eb |
| publicationDate | 2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016072650-A1 |
| titleOfInvention | Pharmaceutical composition, containing ift46, for alleviating polycystic kidney disease, and ift46 gene condition-defective autosomal dominant polycystic kidney disease animal model |
| abstract | The present invention relates to a pharmaceutical composition, containing IFT46, for alleviating polycystic kidney disease, and to an Ift46 gene condition-defective autosomal dominant polycystic kidney disease animal model. As the IFT46 expression decreases, the formation of cysts increases and the damage of filaments appears, which correspond to symptoms associated with autosomal dominant polycystic kidney disease, and thus the pharmaceutical composition, containing the IFT46 protein or the gene encoding the protein, for alleviating polycystic kidney disease, can be used to treat autosomal dominant polycystic kidney disease. In addition, the Ift46 gene condition-defective autosomal dominant polycystic kidney disease animal model can be used in researching therapeutic methods for autosomal dominant polycystic kidney disease or screening candidate therapeutic materials therefor. |
| priorityDate | 2014-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.